Xingmai Technology

Xingmai Technology

杏脉科技

Xingmai Technology

Biotech/Healthcare

Xingmai's product portfolio primarily focuses on AI applications in radiology, ultrasound, and pathology. According to CTO Fang Qu, the company has launched products for hospital testing that cover lung conditions, orthopedics, respiratory viruses, and TCT-based cervical cancer screening.

Latest round: Strategic (2022)

Source: ChinaBulls — chinabulls.com

Last updated 2022-08-01

Funding history

Request access to view this section.

Investors

Request access to view this section.

HQ & website

Request access to view this section.

Tags

Request access to view this section.